| Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas KE Evoy, LG Hill, L Groff, L Mazin, CC Carlson, KR Reveles Jama 320 (18), 1934-1937, 2018 | 60 | 2018 |
| Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA LG Hill, LJ Loera, KE Evoy, ML Renfro, SB Torrez, CM Zagorski, JC Perez, ... Addiction 116 (6), 1505-1511, 2021 | 49 | 2021 |
| Operation naloxone: overdose prevention service learning for student pharmacists LG Hill, JP Sanchez, SA Laguado, KA Lawson Currents in Pharmacy Teaching and Learning 10 (10), 1348-1353, 2018 | 37 | 2018 |
| Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas KE Evoy, L Groff, LG Hill, W Godinez, R Gandhi, KR Reveles Journal of the American Pharmacists Association 60 (1), 81-86, 2020 | 33 | 2020 |
| Mobilizing pharmacists to address the opioid crisis: a joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of … SA Coon, LG Hill, RW Hutchison, LM Arnold, JB Jarrett, AR Ottney, ... Journal of the American College of Clinical Pharmacy 3 (8), 1493-1513, 2020 | 30 | 2020 |
| Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic AM Peckham, J Ball, MD Colvard, D Dadiomov, LG Hill, SD Nichols, ... American Journal of Health-System Pharmacy 78 (7), 613-618, 2021 | 29 | 2021 |
| Naloxone Counseling for Harm Reduction and Patient Engagement. JK Han, LG Hill, ME Koenig, N Das Family medicine 49 (9), 730-733, 2017 | 25 | 2017 |
| Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 US states LG Hill, LJ Loera, SB Torrez, T Puzantian, KE Evoy, DJ Ventricelli, ... Drug and alcohol dependence 237, 109518, 2022 | 24 | 2022 |
| Considering the potential benefits of over-the-counter naloxone KE Evoy, LG Hill, CS Davis Integrated Pharmacy Research and Practice, 13-21, 2021 | 24 | 2021 |
| Interprofessional education: principles and application. An update from the American College of Clinical Pharmacy JE Murphy, AM Liles, AL Bingham, KW Chamberlin, DK Dang, LG Hill, ... Journal of the American College of Clinical Pharmacy 1 (1), e17-e28, 2018 | 22 | 2018 |
| Report of the 2020 special committee on substance use and pharmacy education T Tran, J Ball, JP Bratberg, EM DeSimone, TS Franko, LG Hill, ... American journal of pharmaceutical education 84 (11), 8421, 2020 | 21 | 2020 |
| Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction LG Hill, KE Evoy, KR Reveles Journal of the American Pharmacists Association 59 (6), 779-782, 2019 | 18 | 2019 |
| Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: a national survey of community-based pharmacists LG Hill, AE Light, TC Green, AL Burns, PS Zadeh, PR Freeman Journal of the American Pharmacists Association 63 (1), 252-260. e6, 2023 | 15 | 2023 |
| Increasingly powerful opioid antagonists are not necessary LG Hill, CM Zagorski, LJ Loera The International Journal on Drug Policy 99, 103457, 2022 | 15 | 2022 |
| Opioid harm reduction: a scoping review of physician and system-level gaps in knowledge, education, and practice E Gugala, O Briggs, LR Moczygemba, CM Brown, LG Hill Substance Abuse 43 (1), 972-987, 2022 | 13 | 2022 |
| Implementation of a collaborative model for opioid overdose prevention on campus LG Hill, LK Holleran Steiker, L Mazin, ML Kinzly Journal of American college health 68 (3), 223-226, 2020 | 13 | 2020 |
| Impact of physician–pharmacist covisits at a primary care clinic in patients with uncontrolled diabetes J Peterson, A Hinds, A Garza, J Barner, L Hill, M Nguyen, P Lai, T Gums Journal of Pharmacy Practice 33 (3), 321-325, 2020 | 11 | 2020 |
| Isotonitazene as a contaminant of concern in the illegal opioid supply: a practical synthesis and cost perspective CM Zagorski, JM Myslinski, LG Hill The International journal on drug policy 86, 102939, 2020 | 10 | 2020 |
| Reducing the harms of xylazine: clinical approaches, research deficits, and public health context CM Zagorski, RA Hosey, C Moraff, A Ferguson, M Figgatt, S Aronowitz, ... Harm reduction journal 20 (1), 141, 2023 | 9 | 2023 |
| Naloxone accessibility without an outside prescription from US community pharmacies: a systematic review RK Lai, KE Friedson, KR Reveles, K Bhakta, G Gonzales, LG Hill, ... Journal of the American Pharmacists Association 62 (6), 1725-1740, 2022 | 9 | 2022 |
Kelly R RevelesThe University of Texas at AustinVerified email at utexas.edu
